Water-soluble contrast agent use in adhesional small bowel obstruction: a survey of surgical practices and clinical trial considerations
The survey revealed widespread acceptance of WSCA as a therapeutic tool in ASBO among emergency general surgeons. Although practices around its administration varied, there was a clear readiness to adopt standardised protocols. The majority of respondents expressed support for a controlled trial comparing WSCA against a placebo.
Authors
- Josephine Walshaw (ORCID: https://orcid.org/0000-0003-0450-273X)
- Neil Smart (ORCID: https://orcid.org/0000-0002-3043-8324)
- Matthew J. Lee (ORCID: https://orcid.org/0000-0001-9971-1635)
- Adam Peckham-Cooper (ORCID: https://orcid.org/0000-0001-5660-5314)
- Kelsey Aimar (ORCID: https://orcid.org/0000-0003-1701-935X)
- Laura Magill (ORCID: https://orcid.org/0000-0003-2498-8407)
Institutions
- University of Leeds (GB)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Leeds Teaching Hospitals NHS Trust (GB)
- Royal Devon & Exeter NHS Foundation Trust (GB)
- Cancer Research UK Clinical Trials Unit (GB)
- University of Birmingham (GB)
Publication Details
- Journal
- Annals of The Royal College of Surgeons of England
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1308/rcsann.2024.0121
- Citations
- 2
- Primary Topic
- Intestinal and Peritoneal Adhesions
- Type
- article
- Field-Weighted Citation Impact
- 4.01